Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
Submitted by
admin
on January 23, 2018 - 9:00pm
Source:
Endpoints
News Tags:
JNJ
Remicade
drug pricing
Pfizer
biosimilars
Headline:
J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
Do Not Allow Advertisers to Use My Personal information
